Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.
Comparative two-dimensional proteome analysis was used to identify proteins differentially expressed in multiple clinical normal and breast cancer tissues. One protein, the expression of which was elevated in invasive ductal and lobular breast carcinomas when compared with normal breast tissue, was...
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Journal article |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
2003
|
| _version_ | 1826260941363216384 |
|---|---|
| author | Adam, P Berry, J Loader, J Tyson, K Craggs, G Smith, P De Belin, J Steers, G Pezzella, F Sachsenmeir, K Stamps, A Herath, A Sim, E O'Hare, M Harris, A Terrett, J |
| author_facet | Adam, P Berry, J Loader, J Tyson, K Craggs, G Smith, P De Belin, J Steers, G Pezzella, F Sachsenmeir, K Stamps, A Herath, A Sim, E O'Hare, M Harris, A Terrett, J |
| author_sort | Adam, P |
| collection | OXFORD |
| description | Comparative two-dimensional proteome analysis was used to identify proteins differentially expressed in multiple clinical normal and breast cancer tissues. One protein, the expression of which was elevated in invasive ductal and lobular breast carcinomas when compared with normal breast tissue, was arylamine N-acetyltransferase-1 (NAT-1), a Phase II drug-metabolizing enzyme. NAT-1 overexpression in clinical breast cancers was confirmed at the mRNA level and immunohistochemical analysis of NAT-1 in 108 breast cancer donors demonstrated a strong association of NAT-1 staining with estrogen receptor-positive tumors. Analysis of the effect of active NAT-1 overexpression in a normal luminal epithelial-derived cell line demonstrated enhanced growth properties and etoposide resistance relative to control cells. Thus, NAT-1 may not only play a role in the development of cancers through enhanced mutagenesis but may also contribute to the resistance of some cancers to cytotoxic drugs. |
| first_indexed | 2024-03-06T19:13:40Z |
| format | Journal article |
| id | oxford-uuid:17a052f0-ee3d-4da5-a2df-dabca28b7db3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:13:40Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:17a052f0-ee3d-4da5-a2df-dabca28b7db32022-03-26T10:38:35ZArylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:17a052f0-ee3d-4da5-a2df-dabca28b7db3EnglishSymplectic Elements at Oxford2003Adam, PBerry, JLoader, JTyson, KCraggs, GSmith, PDe Belin, JSteers, GPezzella, FSachsenmeir, KStamps, AHerath, ASim, EO'Hare, MHarris, ATerrett, JComparative two-dimensional proteome analysis was used to identify proteins differentially expressed in multiple clinical normal and breast cancer tissues. One protein, the expression of which was elevated in invasive ductal and lobular breast carcinomas when compared with normal breast tissue, was arylamine N-acetyltransferase-1 (NAT-1), a Phase II drug-metabolizing enzyme. NAT-1 overexpression in clinical breast cancers was confirmed at the mRNA level and immunohistochemical analysis of NAT-1 in 108 breast cancer donors demonstrated a strong association of NAT-1 staining with estrogen receptor-positive tumors. Analysis of the effect of active NAT-1 overexpression in a normal luminal epithelial-derived cell line demonstrated enhanced growth properties and etoposide resistance relative to control cells. Thus, NAT-1 may not only play a role in the development of cancers through enhanced mutagenesis but may also contribute to the resistance of some cancers to cytotoxic drugs. |
| spellingShingle | Adam, P Berry, J Loader, J Tyson, K Craggs, G Smith, P De Belin, J Steers, G Pezzella, F Sachsenmeir, K Stamps, A Herath, A Sim, E O'Hare, M Harris, A Terrett, J Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. |
| title | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. |
| title_full | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. |
| title_fullStr | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. |
| title_full_unstemmed | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. |
| title_short | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. |
| title_sort | arylamine n acetyltransferase 1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro |
| work_keys_str_mv | AT adamp arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT berryj arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT loaderj arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT tysonk arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT craggsg arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT smithp arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT debelinj arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT steersg arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT pezzellaf arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT sachsenmeirk arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT stampsa arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT heratha arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT sime arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT oharem arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT harrisa arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro AT terrettj arylaminenacetyltransferase1ishighlyexpressedinbreastcancersandconveysenhancedgrowthandresistancetoetoposideinvitro |